Latest Breaking News On - Annual scientific - Page 11 : comparemela.com

Study questions routine use of beta blockers after heart attack

Taking beta blockers after a heart attack did not significantly reduce the risk of death or a second heart attack among people with normal heart pumping ability, as indicated by an ejection fraction of 50% or higher, according to a study presented at the American College of Cardiology's Annual Scientific Session.

New zealandTroels yndigegnAmerican college of cardiology annual scientific sessionSwedish heart lung foundationAmerican college of cardiologyStockholm county councilLund universitySwedish research councilAmerican collegeAnnual scientificStockholm countyNew england journalHeart attackBlood pressureHeart failureMyocardial infarction

Study shows promise of zilebesiran injection in reducing systolic blood pressure

A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to 12 mmHg on average at three months in patients whose blood pressure had remained uncontrolled despite compliance with their medication regimen, according to a study presented at the American College of Cardiology's Annual Scientific Session.

United statesAkshay desaiAmerican college of cardiologyAlnylam pharmaceuticalsAmerican college of cardiology annual scientific sessionUs centers for diseaseAmerican collegeAnnual scientificDisease controlBlood pressureBlood vesselsHigh blood pressure

ACE inhibitor not protective against heart damage from chemotherapy

ACE inhibitor not protective against heart damage from chemotherapy
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United kingdomRedcar and clevelandDavid austinJames cook university hospitalAmerican college of cardiology annual scientific sessionAmerican collegeAnnual scientificSouth tees

Edetate disodium-based chelation ineffective for heart attack patients with diabetes

People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy that draws lead and other toxic metals linked to increased risk of heart disease and stroke out of the body, according to a study presented at the American College of Cardiology's Annual Scientific Session.

United statesNational institutes of healthAmerican college of cardiologyAmerican college of cardiology annual scientific sessionDrug administrationAmerican collegeAnnual scientificColumbia university divisionMount sinai medical centerNorth americaNational institutes

Preventive percutaneous coronary intervention for high-risk coronary plaques found to reduce cardiac events

Preventive percutaneous coronary intervention for high-risk coronary plaques found to reduce cardiac events
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

South koreaSoult ukpyolsiUniversity of ulsan college medicineAmerican college of cardiology annual scientific sessionDivision of cardiology at asan medical centerAmerican collegeAnnual scientificSeung jung parkAsan medical centerUlsan collegeEast asia